Ultra-high field (UHF, B0 ≥ 7T) MRI provides substantial gains in signal-to-noise ratio, spatial resolution, and contrast. Routine clinical deployment has been limited by challenges of transmit field (B1+) inhomogeneity and specific absorption rate (SAR). Parallel transmission (pTx) can mitigate these challenges but it requires per-channel complex B1+ maps to design effective pTx pulses. We review established and emerging approaches to obtain these maps. We begin by summarizing the underlying physical principles and theory. Then we describe methods for magnitude B1+-mapping such as actual flip-angle imaging (AFI), saturation-prepared B1+-mapping (e.g. SatTFL), and dual refocusing echo acquisition mode (DREAM) that are the basis of widely-applied per-channel complex B1+ mapping methods, as well as methods of pedagogical and/or historical relevance. Next, we describe how relative B1+-mapping with low-flip angle gradient-recalled echo (GRE) scans can determine the relative phases (and relative magnitudes) of B1+ for each channel. We recap the important interferometric approach that is now widely used. We explain how magnitude and phase maps are combined into complex per-channel B1+-maps. We discuss remaining arbitrary factors such as the position-dependent transmit reference phase. We discuss recent practical implementations such as Sandwich TFL, 3DREAM, compressed-sensing SA2RAGE, and respiratory-resolved B1+ mapping. We explore the workflow improvements that could accrue if per-channel B1+ maps don’t need to be acquired for every subject. This includes deep-learning-based approaches to synthesize B1+-maps from the normal localizer scans, the Universal Pulses (UPs) approach to pre-calibrate pulses, and variants such as standardized universal pulses (SUPs), and Fast-Online Customized (FOCUS) and machine-learning online customization. We hope to encourage greater openness and harmonization of these critical calibration steps for parallel transmit pulse design. This will become increasingly important as 7T pTx MRI is adopted for multisite cross-vendor clinical research studies and to deliver the full scientific potential of new extremely high field human MRIs.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: